TrialThe lancet. Diabetes & endocrinology2019

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.

Thomas R Pieber et al.PubMed ↗Publisher ↗

No numbers read from the abstract.